Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Exp Vaccine Res ; 11(2): 209-216, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35799870

RESUMO

Purpose: This study was performed to investigate humoral immune response and adverse events upon the heterologous prime-boost with a single dose of the mRNA-1273 vaccine among fully CoronaVac-vaccinated, infection-naïve healthcare workers in Indonesia. Materials and Methods: One hundred twenty-five eligible healthcare workers were recruited from one hospital for this prospective cohort study. Blood collection was conducted twice, i.e., on 7 days before and 28 days after the booster vaccination. The titer of anti-SARS-CoV-2 receptor-binding domain (RBD) antibodies was quantified accordingly. The post-vaccination adverse event was recorded for both CoronaVac and mRNA-1273 vaccinations. Any breakthrough infection was monitored during the follow-up period. Wilcoxon matched-pairs signed rank test was used to test differences between groups. Results: A significant increase was observed in the titer of anti-SARS-CoV-2 RBD antibodies upon receiving the mRNA-1273 booster (geometric mean titers of 65.57 and 47,445 U/mL in pre- and post-booster, respectively), supporting the argument to use heterologous prime-boost vaccination to improve the protection against COVID-19 in a high-risk population. The mRNA-1273 vaccine, however, caused a higher frequency of adverse events than the CoronaVac vaccine. Nonetheless, the adverse events were considered minor medical events and temporary as all subjects were not hospitalized and fully recovered. Of note, no breakthrough infection was observed during the follow-up to 12 weeks post-booster. Conclusion: The heterologous prime-boost vaccination of healthcare workers with a single dose of the mRNA-1273 vaccine generated a significant elevation in humoral immune response towards RBD of SARS-CoV-2 and was associated with a higher frequency, but minor and transient, adverse events.

2.
Heliyon ; 5(12): e02922, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31867456

RESUMO

The depletion of fossil fuel reserves requires advance anticipation through the search for alternative energy from renewable natural resources. Microalgae have been known as potential organisms for biodiesel feedstock. However, in order to be developed on a large scale, microalgae must have superior traits so that further development becomes more comfortable and cheaper. Tropical lakes are a source of superior microalgae adapted to moderate conditions which can later save operational costs in large-scale production. Situ Gintung and Situ Pamulang are the two largest lakes in South Tangerang, Indonesia and are potential sources of microalgae. Four microalgae isolates from both lakes have been identified, and their potential has been examined. Within an observation period of 18 days, they showed similar growth patterns reaching more than 108 cells mL-1 on day 14 and were able to resist increasing pH. The microalgae were identified through morphological observations and the sequencing of 23S rRNA genes with phylogenetic analysis. Each strain has a positive quality. Isolate G4-3, which was identified as Micractinium conductrix, and P5-4, which was identified as Monoraphidium sp., yielded biomass that exceeded 1.2 g L-1 with lipid content exceeding 60%. Likewise, G4-9, which was also identified as Micractinium conductrix, and P2-15, which was identified as Choricystis parasitica, have lipid content which accounted for 89.10% and 57.48%, respectively; although their biomass was lower. The percentage of fatty acid methyl esters of the four microalgae achieved >60-80%; thus, meeting the standard of biodiesel properties. Therefore, the microalgae isolates have great potential for being developed as biodiesel feedstock.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA